Home › Funds › Point72 Asset Management › LCTX
Point72 Asset Management position in LCTX
LINEAGE CELL THERAPEUTICS IN · Health Care
Latest position (Q1 2026)304.36K sh
Reported value held$480.89K
Portfolio Weight0.00%
First reportedQ1 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 13.79K | $20.68K | New |
| Q4 2025 | 159.41K | $266.21K | New |
| Q1 2026 | 304.36K | $480.89K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LCTX
- BlackRock Inc 13.19M sh · $17.27M · Q2 2026
- Vanguard Group 9.64M sh · $16.11M · Q4 2025
- Geode Capital Management 5.30M sh · $6.94M · Q2 2026
- Millennium Management 3.02M sh · $3.95M · Q2 2026
- Northern Trust Corp 1.66M sh · $2.17M · Q2 2026
- Morgan Stanley 1.47M sh · $1.93M · Q2 2026
- Renaissance Technologies 1.34M sh · $1.76M · Q2 2026
- Marshall Wace 1.28M sh · $1.68M · Q2 2026
- UBS Group AG 687.05K sh · $900.04K · Q2 2026
- Charles Schwab Investment Management 577.43K sh · $756.44K · Q2 2026
- Goldman Sachs Group 433.27K sh · $567.58K · Q2 2026
- Bank of America Corp 424.37K sh · $555.93K · Q2 2026